BACE2 and early-onset autosomal dominant Alzheimer disease: BACE2 is a molecule that has been well studied in neurodegenerative diseases as the enzyme cleaving APP, the precursor of amyloid-β peptides (Aβ), a hallmark of Alzheimer’s disease [39].